Frédérique Vieville
General Counsel bei PHAXIAM THERAPEUTICS S.A.
Ursprung des Netzwerks ersten Grades von Frédérique Vieville
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 16 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Frédérique Vieville
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| TRANSGENE | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| CLASQUIN | Other Transportation | Human Resources Officer | |
| RENOVARO INC. | Biotechnology | Chief Executive Officer | |
| BIOHEMP INTERNATIONAL, INC. | Pharmaceuticals: Major | Director/Board Member | |
| BIOMÉRIEUX | Medical Specialties | Director/Board Member Sales & Marketing | |
Rhone Poulenc Rorer
 Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Chemicals: Specialty | Corporate Officer/Principal | |
Egalet Ltd.
 Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member | |
MSD Vaccines Ltd.
 MSD Vaccines Ltd. Pharmaceuticals: OtherHealth Technology MSD Vaccines Ltd. manufactures and supplies vaccines. Its main way of achieving this goal is to develop and make available innovative vaccines against a wide spectrum of diseases. It also dedicated to increasing the understanding of the value of vaccines and vaccination by providing relevant and accurate information on their quality, safety and efficacy. The company was founded in 1975 and is headquartered in Maidenhead, the United Kingdom. | Pharmaceuticals: Other | Chairman | |
| Katholieke Universiteit Leuven | College/University | Graduate Degree Graduate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin Masters Business Admin | |
| ESCP Europe Campus Paris | College/University | Undergraduate Degree | |
Vlaams Instituut voor Biotechnologie - Flanders Institute
 Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium. | College/University | Director/Board Member Corporate Officer/Principal | |
| European Vaccine Manufacturers | President | ||
| University of Lyon | College/University | Doctorate Degree Doctorate Degree | |
| University of Grenoble | College/University | Doctorate Degree | |
| Grenoble Ecole de Management | College/University | Graduate Degree | |
Graftys SA
 Graftys SA Medical SpecialtiesHealth Technology Graftys SA designs, manufactures and markets calcium phosphate-based synthetic bone substitutes to the global orthopedic and dental surgery markets. Its research and development projects include injectable and resorbable synthetic bone substitutes, biological repair of cartilage and of the spine, as well as bone substitutes combined with pharmaceutical agents. The company was founded by Jean Marc Ferrier, Alain Valet, Jean-Michel Bouler and Aurélien Valet in September 2005 and is headquartered in Aix-en-Provence, France. | Medical Specialties | Director/Board Member | |
FlandersBio vzw
 FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Mouvement des Entreprises de France
 Mouvement des Entreprises de France Miscellaneous Commercial ServicesCommercial Services Mouvement des Entreprises de France operates a network for entrepreneurs. The non-profit company is based in Paris, France. The CEO of the French company is Philippe Pascal Rene Gautier. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Institut Supérieur des Affaires | College/University | Masters Business Admin | |
Renovaro Biosciences Denmark ApS
 Renovaro Biosciences Denmark ApS Miscellaneous Commercial ServicesCommercial Services Dandrit Biotech A/S conducts clinical research, trading, and manufacturing for the pharmaceutical industry. It focuses on research and development of medicines. The company was founded on April 1, 2001 and is headquartered in Hørsholm, Denmark. | Miscellaneous Commercial Services | Chief Executive Officer | |
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
 Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. engages in theresearch and development, and manufacture of immunotherapies for the treatment of oncology and infectious diseases. Its business scope includes biopharmaceutical technology development, technology transfer, and related technical advisory services. The company was founded on July 26, 2010 and is headquartered in Tianjin, China. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Kellogg School of Management | College/University | Masters Business Admin | |
| Dandrit Corp. Pte Ltd. | Chief Executive Officer | ||
| Novicol International Holding, Inc. | Director/Board Member | ||
| BioVision | Chairman | ||
| Myasterix | Director/Board Member | ||
Immunethep SA
 Immunethep SA BiotechnologyHealth Technology Immunethep SA develops biological products. It specializes in anti-bacterial immunotherapies based on the discovery of a virulence mechanism shared by different bacteria that cause life-threatening infections. The company was founded by Pedro Madureira and Bruno Santos and is headquartered in Cantanhede, Portugal. | Biotechnology | Director/Board Member | |
| OSE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Horama SA
 Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
| ACTICOR BIOTECH SAS | Biotechnology | Director/Board Member | |
| Harvard Aids Initiative | Corporate Officer/Principal | ||
| Grenoble Institute of Political Studies | College/University | Undergraduate Degree | |
Inhatarget Therapeutics
 Inhatarget Therapeutics Pharmaceuticals: MajorHealth Technology Inhatarget Therapeutics is a Belgian company that is developing targeted inhalation formulations to improve treatment for severe respiratory diseases, with a first focus on lung cancer. The company is based in Brussels, Belgium. The company is currently conducting clinical trials in 5 hospitals. The company's main objective is to create an inhaled chemotherapy for the treatment of lung cancer. | Pharmaceuticals: Major | Director/Board Member | |
| GENFLOW BIOSCIENCES PLC | Biotechnology | Founder | |
| Bsim Therapeutics Ltd. | Director/Board Member |
Statistik
International
| Frankreich | 24 |
| Vereinigte Staaten | 8 |
| Belgien | 7 |
| Kanada | 4 |
| Vereinigtes Königreich | 4 |
Sektoral
| Health Technology | 26 |
| Consumer Services | 11 |
| Commercial Services | 5 |
| Finance | 2 |
| Transportation | 2 |
Operativ
| Director/Board Member | 82 |
| Corporate Officer/Principal | 39 |
| Independent Dir/Board Member | 24 |
| Chief Executive Officer | 20 |
| Chairman | 17 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Eric Jean Marie Leire | 27 |
| Philippe Archinard | 24 |
| Didier Hoch | 24 |
| Hilde Windels | 18 |
| Gil Beyen | 18 |
| Martine George | 18 |
| Eric Soyer | 11 |
| Leila Nicolas | 9 |
| Thibaut du Fayet | 8 |
| Jérôme Bailly | 6 |
| Anne-Cécile Fumey | 6 |
| Robert Sebbag | 6 |
| Céline Breda | 3 |
| Cindy Fevre | 3 |
| Pascal Birman | 3 |
- Börse
- Insiders
- Frédérique Vieville
- Unternehmensverbindungen
